3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
29
Neoplasms
28
Depression
25
Fatigue
18
Prostatic Neoplasms
12
Anxiety Disorders
12
Pain
8
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Colonic Neoplasms
6
Vomiting
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Nausea
5
Multiple Myeloma
5
Uterine Cervical Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Acute
4
Head and Neck Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Burkitt Lymphoma
4
Testicular Neoplasms
3
Neuroblastoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
Therapeutics
1
Risk Assessment
1
Influenza Vaccines
1
Focus Groups
1
Counseling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Patient Acceptance of Health Care
×
Therapeutics
×
Clear all
NCT07024329
2026-04-30
RESPONd
University of Calgary
Phase NA
Recruiting
1,055 enrolled